Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
US9726670B2 · kind B2 · utility
6Cited by
10References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2008 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Jul 10, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70567
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for the in vitro diagnosis of colorectal cancer by determining the presence of Liver Fatty Acid-Binding Protein, ACE and CA19-9 tumor markers in a biological sample taken from a patient suspected of having colorectal cancer. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.